David Hung
(Dr. David Hung M.D.)
Currently holds positions in Establishment Labs Holdings Inc and Novocure Ltd
Performance
Average Return
-12.5%
30 Days8.2%
90 Days15.1%
120 DaysSuccess Rate
50%
30 Days68%
90 Days82%
120 DaysPositions
| Position | Company | Period |
|---|---|---|
| Independent Director | Establishment Labs Holdings Inc | Jan. 1, 2016 - |
| Independent Director | Novocure Ltd | May 31, 2018 - |
| Chief Executive Officer, Director | Axovant Gene Therapies Ltd | April 7, 2017 - Feb. 12, 2018 |
| President, Chief Executive Officer, Director | Medivation Inc | Dec. 17, 2004 - Sept. 28, 2016 |
David Hung's trades of Nuvation Bio Inc's stock
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
